<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03488654</url>
  </required_header>
  <id_info>
    <org_study_id>Heart-SLE</org_study_id>
    <nct_id>NCT03488654</nct_id>
  </id_info>
  <brief_title>CMR-Lupus Comprehensive Approach by Cardiovascular Magnetic Resonance Tomography</brief_title>
  <official_title>The Heart in Systemic Lupus Erythematosus - a Comprehensive Approach by Cardiovascular Magnetic Resonance Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In systemic lupus erythematosus (SLE), cardiac manifestations, e.g. coronary artery disease
      (CAD) and myocarditis are leading causes of morbidity and mortality. The prevalence of
      subclinical heart disease in SLE is unknown. We studied whether a comprehensive
      cardiovascular magnetic resonance (CMR) protocol may be useful for early diagnosis of heart
      disease in SLE patients without known CAD
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitement problems as single centre study
  </why_stopped>
  <start_date type="Actual">July 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of cardiovascular pathologies identified by CMR in patients with SLE</measure>
    <time_frame>at baseline</time_frame>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Lupus Erythematosus, Systemic</condition>
  <condition>Coronary Artery Disease</condition>
  <condition>Myocardial Disease</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiovascular magnetic resonance</intervention_name>
    <description>CMR including cine, late gadolinium enhancement (LGE) and stress perfusion sequences</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with diagnosed SLE
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of SLE, as defined by the American College of Rheumatology Classification
             Criteria for Systemic Lupus Erythematosus

        Exclusion Criteria:

          -  age under 18 years

          -  known coronary artery disease

          -  impaired renal function with an estimated glomerular filtration rate less than 30
             ml/min, estimated by the Modification of Diet in Renal Disease Study Group (MDRD)
             formula (45)

          -  devices as pacemakers, implantable cardioverter-defibrillators, insulin pumps and
             others

          -  metallic foreign bodies in the eyes, ferromagnetic implants labeled MR unsafe

          -  allergy against CMR contrast media or adenosine

          -  presence of chronic atrial fibrillation, 2nd or 3rd degree Atrioventricular
             (AV)-block, trifascicular block, asthma and severe chronic obstructive pulmonary
             disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thilo Burkard</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2018</study_first_submitted>
  <study_first_submitted_qc>March 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2018</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

